Abstract
Penile ultrasound is commonly used in the diagnostic workup of patients with erectile dysfunction (ED), but also plays an important role by providing an anatomic and functional assessment in a multitude of other conditions including Peyronie’s disease, priapism, penile fracture, penile urethral strictures, urethral stones, or diverticulae, or masses involving deep tissues of the penis. As a component of the evaluation for ED, penile Doppler ultrasound (PDU) is performed to assess the quality of arterial blood flow and sufficiency of veno-occlusive mechanisms, both necessary for adequate erections. More recently, PDU is playing a central role in the early detection of otherwise silent coronary artery disease (CAD) in men presented with ED as their initial symptom. PDU is also an essential component of the assessment of external genitalia in trauma situations. Penile ultrasound provides a readily available, minimally invasive diagnostic modality that evaluates both the structural anatomy and functional hemodynamics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Doubilet PM, et al. The penis. Semin Ultrasound CT MR. 1991;12(2):157–75.
http://www.auanet.org/content/guidelines-and-quality-care/policy-statements.cfm.
Shin D, Pregenzer G Jr, Gardin JM. Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev. 2011;19(1):5–11.
Tomada N, et al. Are all metabolic syndrome components responsible for penile hemodynamics impairment in patients with erectile dysfunction? The role of body fat mass assessment. J Sex Med.
Corona G, et al. Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. J Sex Med. 2010;7(5):1918–27.
Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566–75.
Hayashi T, et al. Lifestyle intervention, behavioral changes, and improvement in cardiovascular risk profiles in the California WISEWOMAN project. J Womens Health (Larchmt). 2010;19(6):1129–38.
Miner MM Erectile dysfunction: a harbinger or consequence: does its detection lead to a “Window of Curability?” J Androl.
Inman BA, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84(2):108–13.
Billups KL, et al. Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res. 2008;20(3):236–42.
Patel U, Lees WR. Penile sonography. In: Solibiati L, Rizzatto G, Editors. Ultrasound of superficial structures. London: Churchill Livingstone; 1995. pp. 229–42.
Wilkins CJ, Sriprasad S, Sidhu PS. Colour Doppler ultrasound of the penis. Clin Radiol. 2003;58(7):514–23.
Kim SH, et al. Doppler sonography of deep cavernosal artery of the penis: variation of peak systolic velocity according to sampling location. J Ultrasound Med. 1994;13(8):591–4.
Roy C, et al. Duplex Doppler sonography of the flaccid penis: potential role in the evaluation of impotence. J Clin Ultrasound. 2000;28(6):290–4.
Mancini M, et al. Duplex ultrasound evaluation of cavernosal peak systolic velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction. Int J Androl. 2000;23(4):199–204.
van Ahlen H, et al. Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum. J Urol. 1994;151(5):1227–30.
Patel U, et al. Colour flow and spectral Doppler imaging after papaverine-induced penile erection in 220 impotent men: study of temporal patterns and the importance of repeated sampling, velocity asymmetry and vascular anomalies. Clin Radiol. 1993;48(1):18–24.
Broderick GA, Lue TF. The penile blood flow study: evaluation of vasculogenic impotence. In: Jonas U, Thon WF, Stief CG, Editors. Erectile dysfunction. Berlin: Springer; 1991.
Shabsigh R, et al. Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence. J Urol. 1990;143(5):924–7.
Benson CB, Vickers MA. Sexual impotence caused by vascular disease: diagnosis with duplex sonography. AJR Am J Roentgenol. 1989;153(6):1149–53.
Lue TF, et al. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology. 1985;155(3):777–81.
Mueller SC, Lue TF. Evaluation of vasculogenic impotence. Urol Clin North Am. 1988;15(1):65–76.
Pescatori ES, et al. A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study. J Urol. 1994;151(5):1209–16.
Benson CB, Aruny JE, Vickers MA Jr. Correlation of duplex sonography with arteriography in patients with erectile dysfunction. AJR Am J Roentgenol. 1993;160(1):71–3.
Bassiouny HS, Levine LA. Penile duplex sonography in the diagnosis of venogenic impotence. J Vasc Surg. 1991;13(1):75–82. (discussion 82–3)
Quam JP, et al. Duplex and color Doppler sonographic evaluation of vasculogenic impotence. AJR Am J Roentgenol. 1989;153(6):1141–7.
Naroda T, et al. Clinical studies for venogenic impotence with color Doppler ultrasonography-evaluation of resistance index of the cavernous artery. Nippon Hinyokika Gakkai Zasshi. 1996;87(11):1231–5.
Cormio L, et al. Resistance index as a prognostic factor for prolonged erection after penile dynamic colour Doppler ultrasonography. Eur Urol. 1998;33(1):94–7.
Feldman HA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med. 2000;30(4):328–38.
Blumentals WA, et al. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res. 2004;16(4):350–3.
Sullivan ME, et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res. 1999;43(3):658–65.
Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003;89(3):251–3.
Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction the “tip of the iceberg” of a systemic vascular disorder? Eur Urol. 2003;44(3):352–4.
Guay AT. The emerging link between hypogonadism and metabolic syndrome. J Androl. 2009;30(4):370–6.
Traish AM, Guay AT Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med. 2006;3(3):382–404. (discussion 404–7)
Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137(5):829–36.
O’Kane PD, Jackson G. Erectile dysfunction: is there silent obstructive coronary artery disease? Int J Clin Pract. 2001;55(3):219–20.
Mulhall J, Teloken P, Barnas J. Vasculogenic erectile dysfunction is a predictor of abnormal stress echocardiography. J Sex Med. 2009;6(3):820–5.
Zambon JP, et al. Cardiovascular and metabolic syndrome risk among men with and without erectile dysfunction: case-control study. Sao Paulo Med J. 2010;128(3):137–40.
Mottillo S, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.
Bohm M, et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation. 121(12):1439–46.
Batty GD, et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol. 2010;56(23):1908–13.
Kang BC, et al. Post-traumatic arterial priapism: colour Doppler examination and superselective arterial embolization. Clin Radiol. 1998;53(11):830–4.
Asgari MA, et al. Penile fractures: evaluation, therapeutic approaches and long-term results. J Urol. 1996;155(1):148–9.
El-Bahnasawy MS, Gomha MA. Penile fractures: the successful outcome of immediate surgical intervention. Int J Impot Res. 2000;12(5):273–7.
Atan A, et al. Idiopathic penile mondors’ disease: a case report. Int Urol Nephrol. 2002;34(1):97–9.
Dicuio M, et al. Doppler ultrasonography in a young patient with penile Mondor’s disease. Arch Ital Urol Androl. 2005;77(1):58–9.
Sasso F, et al. Penile Mondors’ disease: an underestimated pathology. Br J Urol. 1996;77(5):729–32.
Nachmann MM, et al. Sickle cell episode manifesting as superficial thrombophlebitis of the penis. J Am Osteopath Assoc. 2003;103(2):102–4.
Luzzi GA, Pattinson J, Wathen CG. Penile Mondor’s disease and inherited thrombophilia. Int J STD AIDS. 2006;17(1):70–1.
Brock G, et al. The anatomy of the tunica albuginea in the normal penis and Peyronie’s disease. J Urol. 1997;157(1):276–81.
Chou YH, et al. High-resolution real-time ultrasound in Peyronie’s disease. J Ultrasound Med. 1987;6(2):67–70.
Kadioglu A, et al. Color Doppler ultrasound assessment of penile vascular system in men with Peyronie’s disease. Int J Impot Res. 2000;12(5):263–7.
Richards G, Goldenberg E, Pek H, Gilbert BR. Penile sonoelastography for the localization of a non-palpable, non-sonographically visualized lesion in a patient with penile curvature from peyronie’s disease. J Sex Med. 2013;11:5.
Horenblas S, et al. Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology. Urology. 1994;43(5):702–7.
Lont AP, et al. A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int. 2003;91(6):493–5.
Lan SK, et al. Penile metastasis secondary to nasal NK/T-cell lymphoma. Urology. 2008;72(5):1014–5.
Gallentine ML, Morey AF. Imaging of the male urethra for stricture disease. Urol Clin North Am. 2002;29(2):361–72.
Morey AF, McAninch JW. Role of preoperative sonourethrography in bulbar urethral reconstruction. J Urol. 1997;158(4):1376–9.
Choudhary S, et al. A comparison of sonourethrography and retrograde urethrography in evaluation of anterior urethral strictures. Clin Radiol. 2004;59(8):736–42.
Morey AF, McAninch JW. Sonographic staging of anterior urethral strictures. J Urol. 2000;163(4):1070–5.
Kim B, Kawashima A, LeRoy AJ. Imaging of the male urethra. Semin Ultrasound CT MR. 2007;28(4):258–73.
Bearcroft PW, Berman LH. Sonography in the evaluation of the male anterior urethra. Clin Radiol. 1994;49(9):621–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix
Appendix
Patient Instructions for Penile Injection Therapy
I Preparation for Injection
Items You Will Need
-
Alcohol sponges or swaps
-
1 mL insulin syringe with #28 or #30 gauge needle. These are disposable and not to be reused for a second injection. Disposal should be performed with the cap on the needle so as not to injure anyone disposing of trash.
-
Papaverine/Phentomlamine combination, Prostaglandin E1 or Papaverine/Phentolamine/Prostaglandin combination either pre-drawn by the physician a pharmacist in the syringe, or in a vial to be drawn into the syringe by the patient in the appropriate volume as prescribed by the physician. The medication must be refrigerated and away from light exposure.
Filling the Syringe
-
1.
Check the expiration date of medication. Hold the medication bottle so that your fingers do not touch the rub or stopper.
-
2.
Using a circular motion, wipe off the top of the bottle with alcohol swab.
-
3.
Remove the needle cover. Do not allow the need of to touch anything before drawing the medication or before injecting the medication.
-
4.
Draw an amount of the air is cool to the mountain medication to be injected into the syringe. Push the need of and to the center of the stopper. Push the air into the bottle.
-
5.
Turn the bottle and syringe upside down. Solely draw the medication into the syringe. Tap the syringe gently to remove the bubbles.
-
6.
Move the plunger in and out several times while gently tapping the syringe, just removing all air bubbles.
-
7.
Gently removing the old from the bottle and replace the. The soon the protective and place the filled syringe within easy reach prior to injection.
II Self-injection Technique
Step 1
Grasp the head of the penis, not the skin, and hold upwards toward the trunk. Position the penis along your inner thigh. Choose the injection site on the side of the penis. Avoid injecting into any visible veins. The crossed hatched areas in the figure below represent the ideal locations to inject into.
Step 2
Wipe the skin with an alcohol swab.
Step 3
Pick up the syringe between the thumb and middle finger, like a pen, and push the needle gently but firmly through the skin until the entire need is buried inside the penis.
Step 4
Holding the syringe, use your thumb to slowly (8–10 s) inject the entire amount of medication. Then remove the needle with from your penis.
Step 5
Immediately apply pressure on the injection site with another alcohol wipe for at least 2 min. Make sure there is no bleeding.
Step 6
Dispose of the syringe unit into the puncture-proof receptacle provided.
Step 7
Stand up to allow your erection to develop quickly. You are now ready to start sexual foreplay. You will have a full or action within a few minutes.
Normally, the erection will last anywhere from 30–120 min. If your erection lasts longer than 3 h, you should seek immediate medical attention.
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rais-Bahrami, S., Gilbert, B. (2015). Penile Ultrasound. In: Gilbert, B. (eds) Ultrasound of the Male Genitalia. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7744-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7744-0_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7743-3
Online ISBN: 978-1-4614-7744-0
eBook Packages: MedicineMedicine (R0)